ALTATHERA PHARMS LLC
PharmaALTATHERA PHARMS LLC is a pharmaceutical company focused on Cardiovascular.
ALTATHERA PHARMS LLC's Key Drugs
ALTATHERA PHARMS LLC's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
ALTATHERA PHARMS LLC's Recent FDA Approvals
New NDA/BLA approvals for ALTATHERA PHARMS LLC over the last two years — novel drugs only, excluding generics and label supplements.
ALTATHERA PHARMS LLC's Therapeutic Areas
ALTATHERA PHARMS LLC's approved drugs and pipeline span 1 therapeutic area, led by Cardiovascular. Weighted by commercial stage — approved drugs count most, then late-stage trials.
ALTATHERA PHARMS LLC's Top Competitors
ALTATHERA PHARMS LLC's closest competitors by therapeutic-area and drug-target overlap include Novartis, Merck, and Baxter. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.
ALTATHERA PHARMS LLC Pipeline Snapshot
Active clinical trials for ALTATHERA PHARMS LLC across all therapeutic areas, from ClinicalTrials.gov.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Cardiovascular pipeline focus
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 2009-07-02
- Latest
- 2025-07-23
- Applications
- 1